@BRxAD @ABXsteward @ASP_Chat Have you considered studies which use Multiplex PCR testing as well? They'd probably require a separate analysis. https://t.co/GRyyXyj5CC https://t.co/6Gd4yWeqU2 https://t.co/P7yAVZ2iB4 https://t.co/bRuY1GZ54J https://t.co/RTYr
Contou et al. https://t.co/MUl834tyZL Kreitmann et al. https://t.co/2VwspCLbnX Verroken et al. https://t.co/CWvE2GUjnd
"In this prospective cohort analysis, we investigated the respiratory co-infection rate in #COVID19 critically ill through the use of rapid molecular testing and measured its impact on antibiotic management." https://t.co/uQL90xpAi1 #rapidtest https://t.co
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis @Crit_Care | #ECM https://t.co/LOHTpG54kY
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis @Crit_Care | #ECM https://t.co/rht5lxGCrC
RT @biomerieuxcmo: Another hot-off-the-press study: @BioFireDX PneumoniaPlus panel in COVID patients: direct communication of rapid results…
Another hot-off-the-press study: @BioFireDX PneumoniaPlus panel in COVID patients: direct communication of rapid results (75 min) led to antibiotic modifications in 46.9% of patients, including 1/3 of patients remaining antibiotic-free. #diagnosticsispower